Honasa buys majority stake in Fluence Pharma, betting on health-beauty convergence
Mamaearth parent Honasa Consumer has acquired a majority stake in Fluence Pharma, pushing into nutraceuticals and prescription-led segments. The deal signals Indian BPC brands' pivot toward health-beauty convergence to build consumer trust and unlock new growth avenues.
Honasa Consumer (Mamaearth parent) acquired a majority stake in Fluence Pharma, entering nutraceuticals and signaling Indian BPC brands' pivot toward health-beauty convergence and prescription-led segments to build consumer trust and unlock growth.
Why this matters
The Fluence Pharma deal follows Honasa's Q4 profit nearly tripling on 40%+ growth from younger brands, even as VC backer Sofina trimmed its Rs 177 Cr stake. Health-beauty convergence marks Honasa's next growth bet.
Retail-company signals held steady at 4,007 over the past 90 days.
Also reported by
- Mint — Same time